Interrelationship between HIV-1 fitness and mutation rate

Journal of Molecular Biology

Volumn 425, Issue 1, 2013, Pages 41-53

  Dapp, Michael J ^a,c,d   Heineman, Richard H ^a,b   Mansky, Louis M ^a,b,c,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

evolution; fitness; lentivirus; mutation; retrovirus

Indexed keywords

ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ENVELOPE; VIRUS MUTATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; RNA VIRUSES;

EID: 84871772064     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2012.10.009     Document Type: Article

References (98)

1. J.W. Drake, B. Charlesworth, D. Charlesworth, and J.F. Crow Rates of spontaneous mutation Genetics 148 1998 1667 1686
2. J.W. Drake, and J.J. Holland Mutation rates among RNA viruses Proc. Natl Acad. Sci. USA 96 1999 13910 13913
3. R. Sanjuan, M.R. Nebot, N. Chirico, L.M. Mansky, and R. Belshaw Viral mutation rates J. Virol. 84 2010 9733 9748
4. M. Lynch The origins of eukaryotic gene structure Mol. Biol. Evol. 23 2006 450 468
5. J.W. Drake Comparative rates of spontaneous mutation Nature 221 1969 1132
6. J.W. Drake A constant rate of spontaneous mutation in DNA-based microbes Proc. Natl Acad. Sci. USA 88 1991 7160 7164
7. L.M. Mansky, and H.M. Temin Lower in vivo mutation rate of human immunodeficiency virus type 1 than predicted from the fidelity of purified reverse transcriptase J. Virol. 69 1995 5087 5094
8. M.E. Abram, A.L. Ferris, W. Shao, W.G. Alvord, and S.H. Hughes Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication J. Virol. 84 2010 9864 9878
9. P.J. Gerrish, A. Colato, A.S. Perelson, and P.D. Sniegowski Complete genetic linkage can subvert natural selection Proc. Natl Acad. Sci. USA 104 2007 6266 6271
10. I.M. Rouzine, E. Brunet, and C.O. Wilke The traveling-wave approach to asexual evolution: Muller's ratchet and speed of adaptation Theor. Popul. Biol. 73 2008 24 46
11. L.S. Tsimring, H. Levine, and D.A. Kessler RNA virus evolution via a fitness-space model Phys. Rev. Lett. 76 1996 4440 4443
12. J.J. Bull, R. Sanjuán, and C.O. Wilke Theory of lethal mutagenesis for viruses J. Virol. 81 2007 2930 2939
13. M.J. Dapp, C.L. Clouser, S. Patterson, and L.M. Mansky 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1 J. Virol. 83 2009 11950 11958
14. M.J. Dapp, C.M. Holtz, and L.M. Mansky Concomitant lethal mutagenesis of human immunodeficiency virus type 1 J. Mol. Biol. 419 2012 158 170
15. J.P. Anderson, D.R.; and L.A. Loeb Viral error catastrophe by mutagenic nucleosides Annu. Rev. Microbiol. 58 2004 183 205
16. L.A. Loeb, J.M. Essigmann, F. Kazazi, J. Zhang, K.D. Rose, and J.I. Mullins Lethal mutagenesis of HIV with mutagenic nucleoside analogs Proc. Natl Acad. Sci. USA 96 1999 1492 1497
17. R.A. Smith, L.L.; and B.D. Preston Lethal mutagenesis of HIV Virus Res. 107 2005 215 228
18. R.S. Harris, K.N. Bishop, A.M. Sheehy, H.M. Craig, S.K. Petersen-Mahrt, and I.N. Watt DNA deamination mediates innate immunity to retroviral infection Cell 113 2003 803 809
19. K.S. Harris, W. Brabant, S. Styrchak, A. Gall, and R. Daifuku KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis Antiviral Res. 67 2005 1 9
20. Q. Yu, R. Konig, S. Pillai, K. Chiles, M. Kearney, and S. Palmer Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome Nat. Struct. Mol. Biol. 11 2004 435 442
21. M.A. Nowak, R.M. Anderson, A.R. McLean, T.F. Wolfs, J. Goudsmit, and R.M. May Antigenic diversity thresholds and the development of AIDS Science 254 1991 963 969
22. H.Y. Lee, A.S. Perelson, S.C. Park, and T. Leitner Dynamic correlation between intrahost HIV-1 quasispecies evolution and disease progression PLoS Comput. Biol. 4 2008 e1000240
23. L.M. Mansky Retrovirus mutation rates and their role in genetic variation J. Gen. Virol. 79 1998 1337 1345
24. J.M. Coffin HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy Science 267 1995 483 489
25. A.S. Perelson, A.U. Neumann, M. Markowitz, J.M. Leonard, and D.D. Ho HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time Science 271 1996 1582 1586
26. L.M. Mansky HIV mutagenesis and the evolution of antiretroviral drug resistance Drug Resist. Updates 5 2002 219 223
27. J.P. Horst, T.H. Wu, and M.G. Marinus Escherichia coli mutator genes Trends Microbiol. 7 1999 29 36
28. M.D. Gross, and E.C. Siegel Incidence of mutator strains in Escherichia coli and coliforms in nature Mutat. Res. 91 1981 107 110
29. J.E. LeClerc, B. Li, W.L. Payne, and T.A. Cebula High mutation frequencies among Escherichia coli and Salmonella pathogens Science 274 1996 1208 1211
30. I. Matic, M. Radman, F. Taddei, B. Picard, C. Doit, and E. Bingen Highly variable mutation rates in commensal and pathogenic Escherichia coli Science 277 1997 1833 1834
31. P. Suarez, J. Valcarcel, and J. Ortin Heterogeneity of the mutation rates of influenza A viruses: isolation of mutator mutants J. Virol. 66 1992 2491 2494
32. M. Gutierrez-Rivas, and L. Menendez-Arias A mutation in the primer grip region of HIV-1 reverse transcriptase that confers reduced fidelity of DNA synthesis Nucleic Acids Res. 29 2001 4963 4972
33. L.M. Mansky, and L.C. Bernard 3′-Azido-3′-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency type 1 J. Virol. 74 2000 9532 9539
34. L.M. Mansky, D.K. Pearl, and L.C. Gajary Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies J. Virol. 76 2002 9253 9259
35. R. Chen, M. Yokoyama, H. Sato, C. Reilly, and L.M. Mansky Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies J. Virol. 79 2005 12045 12057
36. P.D. Sniegowski, P.J. Gerrish, and R.E. Lenski Evolution of high mutation rates in experimental populations of E. coli Nature 387 1997 703 705
37. T.F. Cooper, and R.E. Lenski Experimental evolution with E. coli in diverse resource environments. I. Fluctuating environments promote divergence of replicate populations BMC Evol. Biol. 10 2010 11
38. A. Giraud, I. Matic, O. Tenaillon, A. Clara, M. Radman, M. Fons, and F. Taddei Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut Science 291 2001 2606 2608
39. C. Pal, M.D. Macia, A. Oliver, I. Schachar, and A. Buckling Coevolution with viruses drives the evolution of bacterial mutation rates Nature 450 2007 1079 1081
40. O. Tenaillon, B. Toupance, H. Le Nagard, F. Taddei, and B. Godelle Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria Genetics 152 1999 485 493
41. T. Johnson Beneficial mutations, hitchhiking and the evolution of mutation rates in sexual populations Genetics 151 1999 1621 1631
42. K.J. Dawson Evolutionarily stable mutation rates J. Theor. Biol. 194 1998 143 157
43. C.H. Lee, D.L. Gilbertson, I.S. Novella, R. Huerta, E. Domingo, and J.J. Holland Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus J. Virol. 71 1997 3636 3640
44. W. Keulen, A. van Wijk, R. Schuurman, B. Berkhout, and C.A. Boucher Increased polymerase fidelity of lamivudine-resistant HIV-1 variants does not limit their evolutionary potential AIDS 13 1999 1343 1349
45. E.G. Leigh Natural selection and mutability Am. Nat. 104 1970 301 305
46. J.K. Pfeiffer, and K. Kirkegaard Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice PLoS Pathog. 1 2005 e11
47. M. Vignuzzi, E. Wendt, and R. Andino Engineering attenuated virus vaccines by controlling replication fidelity Nat. Med. 14 2008 154 161
48. S. Williamson Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression Mol. Biol. Evol. 20 2003 1318 1325
49. H.W. Sheppard, W. Lang, M.S. Ascher, E. Vittinghoff, and W. Winkelstein The characterization of non-progressors: long-term HIV-1 infection with stable CD4 + T-cell levels AIDS 7 1993 1159 1166
50. S.F. Elena, and R. Sanjuan Adaptive value of high mutation rates of RNA viruses: separating causes from consequences J. Virol. 79 2005 11555 11558
51. L.M. Mansky, E. Le Rouzic, S. Benichou, and L.C. Gajary Influence of reverse transcriptase variants, drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies J. Virol. 77 2003 2071 2080
52. M.J. Bessman, N. Muzyczka, M.F. Goodman, and R.L. Schnaar Studies on the biochemical basis of spontaneous mutation. II. The incorporation of a base and its analogue into DNA by wild-type, mutator and antimutator DNA polymerases J. Mol. Biol. 88 1974 409 421
53. M.F. Goodman, W.C. Gore, N. Muzyczka, and M.J. Bessman Studies on the biochemical basis of spontaneous mutation. III. Rate model for DNA polymerase-effected nucleotide misincorporation J. Mol. Biol. 88 1974 223 235
54. J.J. Hopfield Kinetic proofreading: a new mechanism for reducing errors in biosynthetic processes requiring high specificity Proc. Natl Acad. Sci. USA 71 1974 4135 4139
55. V. Furio, A. Moya, and R. Sanjuan The cost of replication fidelity in an RNA virus Proc. Natl Acad. Sci. USA 102 2005 10233 10237
56. V. Furio, A. Moya, and R. Sanjuan The cost of replication fidelity in human immunodeficiency virus type 1 Proc. R. Soc. B 274 2007 225 230
57. N.K. Back, M. Nijhuis, W. Keulen, C.A. Boucher, B.O. Oude Essink, and A.B. van Kuilenburg Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme EMBO J. 15 1996 4040 4049
58. V.N. Pandey, N. Kaushik, N. Rege, S.G. Sarafianos, P.N. Yadav, and M.J. Modak Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis Biochemistry 35 1996 2168 2179
59. C.L. Clouser, S.E. Patterson, and L.M. Mansky Exploiting drug repositioning for discovery of a novel HIV combination therapy J. Virol. 84 2010 9301 9309
60. H. Huang, R. Chopra, G.L. Verdine, and S.C. Harrison Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance Science 282 1998 1669 1675
61. J.L. Moreland, A. Gramada, O.V. Buzko, Q. Zhang, and P.E. Bourne The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications BMC Bioinformatics 6 2005 21
62. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, and H. Weissig The Protein Data Bank Nucleic Acids Res. 28 2000 235 242
63. P.D. Sniegowski, P.J. Gerrish, T. Johnson, and A. Shaver The evolution of mutation rates: separating causes from consequences BioEssays 22 2000 1057 1066
64. R.A. Fisher The Genetical Theory of Natural Selection 1930 Clarendon Press Oxford, England
65. M. Kimura On the evolutionary adjustments of spontaneous mutation rates Genet. Res. 9 1967 11
66. H.A. Orr The rate of adaptation in asexuals Genetics 155 2000 961 968
67. J. Deval, J.M. Navarro, B. Selmi, J. Courcambeck, J. Boretto, and P. Halfon A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions J. Biol. Chem. 279 2004 25489 25496
68. J. Deval, K.L. White, M.D. Miller, N.T. Parkin, J. Courcambeck, and P. Halfon Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations J. Biol. Chem. 279 2004 509 516
69. S.J. Garforth, R.A. Domaoal, C. Lwatula, M.J. Landau, A.J. Meyer, K.S. Anderson, and V.R. Prasad K65R and K65A substitutions in HIV-1 reverse transcriptase enhance polymerase fidelity by decreasing both dNTP misinsertion and mispaired primer extension efficiencies J. Mol. Biol. 401 2010 33 44
70. N.K. Back, and B. Berkhout Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase Antimicrob. Agents Chemother. 41 1997 2484 2491
71. M.A. Wainberg Increased fidelity of drug-selected M184V mutated HIV-1 reverse transcriptase as the basis for the effectiveness of 3TC in HIV clinical trials Leukemia 11 1997 85 88
72. B. Berkhout HIV-1 evolution under pressure of protease inhibitors: climbing the stairs of viral fitness J. Biomed. Sci. 6 1999 298 305
73. M.A. Wainberg, W.C. Drosopoulos, H. Salomon, M. Hsu, G. Borkow, and M.A. Parniak Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase Science 271 1996 1282 1285
74. L.F. Rezende, W.C. Drosopoulos, and V.R. Prasad The influence of 3TC resistance mutation M184I on the fidelity and error specificity of human immunodeficiency virus type 1 reverse transcriptase Nucleic Acids Res. 26 1998 3066 3072
75. J.Y. Feng, and K.S. Anderson Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase Biochemistry 38 1999 9440 9448
76. V.S. Korneeva, and C.E. Cameron Structure-function relationships of the viral RNA-dependent RNA polymerase: fidelity, replication speed, and initiation mechanism determined by a residue in the ribose-binding pocket J. Biol. Chem. 282 2007 16135 16145
77. L. Chao, and E.C. Cox Competition between high and low mutating strains of Escherichia coli Evolution 37 1983 125 134
78. E. Loh, J.J. Salk, and L.A. Loeb Optimization of DNA polymerase mutation rates during bacterial evolution Proc. Natl Acad. Sci. USA 107 2010 1154 1159
79. T.C. Gibson, M.L. Scheppe, and E.C. Cox Fitness of an Escherichia coli mutator gene Science 169 1970 686 688
80. P. Funchain, A. Yeung, J.L. Stewart, R. Lin, M.M. Slupska, and J.H. Miller The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness Genetics 154 2000 959 970
81. L. Notley-McRobb, S. Seeto, and T. Ferenci Enrichment and elimination of MutY mutators in Escherichia coli populations Genetics 162 2002 1055 1062
82. E. Denamur, and I. Matic Evolution of mutation rates in bacteria Mol. Microbiol. 60 2006 820 827
83. S. Crotty, C.E. Cameron, and R. Andino RNA virus error catastrophe: direct molecular test by using ribavirin Proc. Natl Acad. Sci. USA 98 2001 6895 6900
84. J.D. Graci, and C.E. Cameron Therapeutically targeting RNA viruses via lethal mutagenesis Future Virol. 3 2008 553 566
85. A.M. Martin-Hernandez, M. Gutierrez-Rivas, E. Domingo, and L. Menendez-Arias Mispair extension fidelity of human immunodeficiency virus type 1 reverse transcriptases with amino acid substitutions affecting Tyr115 Nucleic Acids Res. 25 1997 1383 1389
86. A.M. Martin-Hernandez, E. Domingo, and L. Menendez-Arias Human immunodeficiency virus type 1 reverse transcriptase: role of Tyr115 in deoxynucleotide binding and misinsertion fidelity of DNA synthesis EMBO J. 15 1996 4434 4442
87. C.E. Cases-Gonzalez, M. Gutierrez-Rivas, and L. Menendez-Arias Coupling ribose selection to fidelity of DNA synthesis. The role of Tyr-115 of human immunodeficiency virus type 1 reverse transcriptase J. Biol. Chem. 275 2000 19759 19767
88. C.G. Anastassopoulou, A.J. Marozsan, A. Matet, A.D. Snyder, E.J. Arts, S.E. Kuhmann, and J.P. Moore Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness loss PLoS Pathog. 3 2007 e79
89. A. Abraha, R.M. Troyer, M.E. Quinones-Mateu, and E.J. Arts Methods to determine HIV-1 ex vivo fitness Methods Mol. Biol. 304 2005 355 368
90. S.C. Ball, A. Abraha, K.R. Collins, A.J. Marozsan, H. Baird, and M.E. Quinones-Mateu Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C J. Virol. 77 2003 1021 1038
91. R.M. Troyer, K.R. Collins, A. Abraha, E. Fraundorf, D.M. Moore, and R.W. Krizan Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression J. Virol. 79 2005 9006 9018
92. Y. Liu, J. McNevin, H. Zhao, D.M. Tebit, R.M. Troyer, and M. McSweyn Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape J. Virol. 81 2007 12179 12188
93. L. Gao, M.N. Hanson, M. Balakrishnan, P.L. Boyer, B.P. Roques, and S.H. Hughes Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of Met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect J. Biol. Chem. 283 2008 9196 9205
94. V.K. Jamburuthugoda, J.M. Santos-Velazquez, M. Skasko, D.J. Operario, V. Purohit, and P. Chugh Reduced dNTP binding affinity of 3TC-resistant M184I HIV-1 reverse transcriptase variants responsible for viral infection failure in macrophage J. Biol. Chem. 283 2008 9206 9216
95. T.L. Diamond, M. Roshal, V.K. Jamburuthugoda, H.M. Reynolds, A.R. Merriam, and K.Y. Lee Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase J. Biol. Chem. 279 2004 51545 51553
96. K.K. Weiss, R. Chen, M. Skasko, H.M. Reynolds, K. Lee, and R.A. Bambara A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis Biochemistry 43 2004 4490 4500
97. cdc2 activity J. Virol. 69 1995 6705 6711
98. A. Gervaix, D. West, L.M. Leoni, D.D. Richmond, F. Wong-Staal, and J. Corbeil A new reporter cell line to monitor HIV infection and drug susceptibility in vitro Proc. Natl Acad. Sci. USA 94 1997 4653 4658